Table 4. Multivariable analyses of SRT vs. SRS stratified by primary cancer site.
Shows the overall survival of patients by primary cancer site.
| Tumor type | Multivariable HR (95% CI) | P |
|---|---|---|
| SRT vs. SRS | ||
| Breast cancer | 1.14 (0.74–1.75) | 0.56 |
| NSCL | 0.94 (0.87–1.01) | 0.11 |
| SCLC | 1.31 (0.89–1.93) | 0.17 |
| Other types of lung cancer | 1.30 (0.92–1.84) | 0.14 |
| Melanoma | 0.93 (0.72–1.21) | 0.59 |
| Colon cancer | 0.42 (0.20–0.85) | 0.01 |
| Kidney cancer | 0.77 (0.54–1.09) | 0.13 |
Notes.
Multivariable analyses were adjusted for age at diagnosis, sex, race, health insurance status, income level, education level, place of living, comorbidity score, chemotherapy, and year of diagnosis.